Soligenix Reports Positive Results in Ongoing CTCL Study
April 14, 2025 — Soligenix reports positive interim results in ongoing study for CTCL treatment, showcasing strong treatment responses and potential breakthrough in addressing unmet medical needs. Learn more about the company's efforts to advance enrollment in a Phase 3 study for potential commercialization worldwide.